|106.16 -0.49 (-0.46%)||11-28 16:00|
|Targets||6-month :||125.15||1-year :||146.17|
|Resists||First :||107.15||Second :||125.15|
|Supports||First :||96.66||Second :||90.19|
|MAs||MA(5) :||106.09||MA(20) :||102.22|
|MA(100) :||92.81||MA(250) :||85.27|
|MACD||MACD :||3.3||Signal :||3.2|
|%K %D||K(14,3) :||93.2||D(3) :||95.8|
|52-week||High :||107.15||Low :||68.52|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CAH ] has closed below upper band by 19.9%. Bollinger Bands are 8.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|If tomorrow:||Open lower||Open higher|
|High:||107.24 - 107.78||107.78 - 108.13|
|Low:||104.65 - 105.38||105.38 - 105.85|
|Close:||105.12 - 106.21||106.21 - 106.91|
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
|Shares Out||246 (M)|
|Shares Float||245 (M)|
|Held by Insiders||0.4 (%)|
|Held by Institutions||90.6 (%)|
|Shares Short||6,930 (K)|
|Shares Short P.Month||7,400 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||-14.14|
|Profit Margin||0 %|
|Operating Margin||0.9 %|
|Return on Assets (ttm)||2.7 %|
|Return on Equity (ttm)||0 %|
|Qtrly Rev. Growth||10.3 %|
|Gross Profit (p.s.)||0|
|Sales Per Share||852.72|
|Qtrly Earnings Growth||-95 %|
|Operating Cash Flow||3,360 (M)|
|Levered Free Cash Flow||3,110 (M)|
|Price to Book value||-7.52|
|Price to Sales||0.12|
|Price to Cash Flow||7.78|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|